Postpartum Anxiety, Depression Not Up After Pandemic Onset, but Benzodiazepine Rx Increased
By Elana Gotkine HealthDay Reporter
TUESDAY, Sept. 17, 2024 -- Among privately insured women, diagnoses of postpartum anxiety and depression did not increase following onset of the COVID-19 pandemic, but there was an increase in the proportion of women filling a benzodiazepine prescription, according to a study published online June 24 in the Archives of Women's Mental Health.
Grace Bagwell Adams, Ph.D., from the University of Georgia in Athens, and colleagues used a retrospective pooled cross-sectional study involving privately insured postpartum women in U.S. claims data from Jan. 1, 2016, to Dec. 31, 2020, to assess trends in diagnosis and treatment of postpartum mood disorders. Changes in diagnoses of anxiety and depression were measured, as were changes in prescription fills and days of supplied classes of medications used to treat these conditions.
The researchers found that diagnoses of depression and anxiety were not significantly higher among privately insured women in the United States following onset of the COVID-19 pandemic in March 2020. There was a 15.2 percent increase in the proportion of privately insured postpartum women filling a benzodiazepine prescription.
"Given the prevalence of perinatal and postpartum mood disorders and the effects of such disorders on the short and long-term health of the mother, it is critical to understand both diagnosis and prescribing patterns for this population," the authors write. "Future research should examine whether these trends of increased prescription fills of benzodiazepines are sustained beyond the end of the COVID-19 pandemic, as well as seek to understand the mechanisms at work to explain these increases."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted September 2024
Further Support and Information on COVID-19
Read this next
Mental Health Care Use, Mortality Rates Increased With Prolonged Grief
FRIDAY, July 25, 2025 -- Relatives bereaved by natural death with high and sustained grief symptoms have increased mental health care use and mortality for up to 10 years after...
Alopecia Areata Associated With Severe Psychosocial Impact
THURSDAY, July 24, 2025 -- Alopecia areata (AA) has a severe psychosocial impact, which is linked to illness perceptions and stigma more strongly than disease severity, according...
Cancer Anxiety Impacts Family Members of Those Diagnosed With Cancer
WEDNESDAY, July 23, 2025 -- A cancer diagnosis places an emotional burden on the loved ones of those diagnosed, according to the results of a survey released by the Ohio State...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.